U.S. Customs and Border Protection (CBP) reported the seizure of a significant quantity of unapproved pharmaceuticals in March 2026, according to recent posts on its official X account.
On April 3, 2026, CBP posted: "https://t.co/BaMTq1WSgi".
Later that day, CBP provided details about the operation: "During March, CBP officers with @DFOChicago seized 351 shipments of air cargo totaling 455lbs of unapproved human growth hormones and steroids. Had they been legitimate, these items would have been valued at over $3.2M.
Read: https://t.co/qOki00YE8Qhttps://t.co/Ajy3x6fDY7" (April 3, 2026).
On April 6, 2026, another post from the agency stated: "https://t.co/RjzjJd8OFW".
Customs and Border Protection is tasked with enforcing laws regulating imports and exports into the United States. The agency routinely intercepts prohibited or unapproved goods to protect public health and safety. Seizures such as those described by CBP reflect ongoing efforts to prevent unauthorized pharmaceuticals from entering U.S. markets.
